StockWatch
·
Pharmaceuticals
Dividend25 May 2026, 12:44 pm

Blue Jet Healthcare Recommends ₹1.2 Final Dividend

AI Summary

Blue Jet Healthcare Ltd's board approved the audited standalone financial results for the year ended March 31, 2026, and recommended a final dividend of ₹1.2 (60%) per equity share of face value ₹2. The dividend is subject to shareholder approval at the upcoming Annual General Meeting. The company also approved a proposal to raise funds up to ₹10,000 million through various instruments. Additionally, M/s. HH. Chimthanawala & Co. were re-appointed as Internal Auditors for FY 2026-27.

Key Highlights

  • Final dividend of ₹1.2 per share (60%) recommended for FY26.
  • Fundraising of up to ₹10,000 million approved via multiple instruments.
  • Audited standalone financial results for FY26 approved.
  • HH. Chimthanawala & Co. re-appointed as Internal Auditors for FY27.
  • Extra-Ordinary General Meeting scheduled for June 17, 2026.